gentamicin has been researched along with pefloxacin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 14 (73.68) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archimbaud, E; Devaux, Y; Fiere, D; Fleurette, J; Guyotat, D; Maupas, J; Nageotte, A; Ploton, C; Thomas, X | 1 |
| Chomarat, M; Gerbaud, G; Vital-Durand, D | 1 |
| Gorski, J; Koch, H; Lange, D; Wehnert, J; Wichmann, G | 1 |
| Chacon, JP; Criscuolo, PD; Ferraro, JR; Kobata, CM; Reis, C; Saad, SS | 1 |
| Edlund, C; Lahnborg, G; Nord, CE | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
| Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
| Bruna, T; Gineston, JL; Lamblin, G; Martorell, J; Poirier, JL; Watine, J | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Lee, EJ; Lye, WC; van der Straaten, J | 1 |
| Helpianska, L; Hlavácová, E; Kollár, T; Kukucková, E; Lacka, J; Sálek, T; Spanik, S; Studená, M; Sufliarsky, J; Trupl, J | 1 |
| Hybenová, D; Majtán, V | 1 |
| Hostacká, A; Majtán, V | 1 |
| Bonina, L; Costa, GB; Mastroeni, P | 1 |
| Andreassi, A; Barachini, P; Bersieri, M; D'Arpa, N; De Bellis, A; Di Lonardo, A; Dioguardi, D; Donati, L; Faggiano, G; Gianfaldoni, R; Gliori, A; Landi, G; Magliacani, G; Magliano, E; Marasco, L; Marinelli, LF; Masellis, M; Micali, G; Novelli, A; Papadia, F; Periti, P; Ranno, R; Rapisarda, V; Savoia, A; Zermani, R | 1 |
| Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
| Karlsson, MO; Milligan, PA; Thomson, AH; Wählby, U | 1 |
7 trial(s) available for gentamicin and pefloxacin
| Article | Year |
|---|---|
Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Infections; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Vancomycin | 1991 |
[A clinical trial of pefloxacin (Abaktal) in the treatment of acute pyelonephritis].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pefloxacin; Pyelonephritis; Randomized Controlled Trials as Topic | 1990 |
Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections.
Topics: Adolescent; Adult; Ampicillin; Cholangitis; Cholecystitis; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Prospective Studies; Remission Induction | 1990 |
A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Pefloxacin; Remission Induction | 1990 |
Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Topics: Administration, Oral; Aged; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Failure; Vancomycin | 1993 |
Once-daily pefloxacin + teicoplanin vs netilmicin + teicoplanin in empirical therapy for fever and neutropenia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Neoplasms; Netilmicin; Neutropenia; Pefloxacin; Teicoplanin | 1995 |
Increased burn patient survival with once-a-day high dose teicoplanin and netilmicin. An Italian multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Body Surface Area; Burns; Child; Drug Therapy, Combination; Female; Gentamicins; Humans; Immunotherapy; Injections, Intramuscular; Italy; Male; Middle Aged; Netilmicin; Pefloxacin; Risk Factors; Sulfadiazine; Teicoplanin; Wound Infection | 1998 |
12 other study(ies) available for gentamicin and pefloxacin
| Article | Year |
|---|---|
[Isolation of a Staphylococcus aureus strain resistant to pefloxacin after treatment with pefloxacin and gentamycin].
Topics: Drug Resistance, Microbial; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Penicillin Resistance; Quinolones; Sepsis; Staphylococcus aureus | 1990 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
In vivo pefloxacin-resistant Campylobacter fetus responsible for gastro-intestinal infection and bacteremia associated with arthritis of the hip.
Topics: Arthritis, Infectious; Bacteremia; Campylobacter fetus; Campylobacter Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Gastrointestinal Diseases; Gentamicins; Hip Joint; Humans; Male; Middle Aged; Pefloxacin | 1995 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Tobramycin; Type C Phospholipases | 1997 |
Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Depression, Chemical; Dose-Response Relationship, Drug; Gentamicins; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence | 1996 |
Comparative effect of gentamicin and pefloxacin treatment on the late stages of mouse typhoid.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Drug Administration Schedule; Female; Gentamicins; Immunity, Cellular; Liver; Male; Mice; Mice, Inbred BALB C; Mononuclear Phagocyte System; Pefloxacin; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1998 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |
Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis.
Topics: Gentamicins; Humans; Models, Chemical; Pefloxacin; Pharmacokinetics; Pharmacology; Pyrimidines; Regression Analysis; Time Factors; Triazoles; Voriconazole | 2004 |